Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Jones

Showing results (521-530 of 654) with videos related to

Pageof 66
Sort By:
The Annals of Thoracic Surgery|June 12, 2024
Outcomes of Patients Undergoing Segmentectomy for Occult Node-Positive Clinical Stage IA Lung CancerTamar B Nobel, Kay See Tan, Prasad S Adusumilli, et al.
Annals of Surgery|January 25, 2020
Outcomes After Multidisciplinary Management of Primary Mediastinal Germ Cell TumorsRaul Caso, Gregory D Jones, Manjit S Bains, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancerHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
JTCVS Open|December 31, 2025
The role of diagnostic laparoscopy in staging distal esophageal adenocarcinomaStella T Tsui, Nanruoyi Zhou, Kay See Tan, et al.
Frontiers in Oncology|January 25, 2021
MYBL2-Driven Transcriptional Programs Link Replication Stress and Error-prone DNA Repair With Genomic Instability in Lung AdenocarcinomaBenjamin B Morris, Nolan A Wages, Patrick A Grant, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 19, 2021
Long-term assessment of efficacy with a novel Thoracic Survivorship Program for patients with lung cancerHari B Keshava, Kay See Tan, Joe Dycoco, et al.
Molecular Cancer Therapeutics|September 19, 2019
Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of <i>Nf1</i>-Deficient MiceCiersten A Burks, Steven D Rhodes, Waylan K Bessler, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 13, 2018
Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysisWhitney S Brandt, Wanpu Yan, Jian Zhou, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 16, 2014
Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trialHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 28, 2022
Postinduction therapy pulmonary function retesting is necessary before surgical resection for non-small cell lung cancerJames G Connolly, Megan Fiasconaro, Kay See Tan, et al.
Pageof 66

Showing results (521-530 of 654) with videos related to

Sort By:
Pageof 66
The Annals of Thoracic Surgery|June 12, 2024
Outcomes of Patients Undergoing Segmentectomy for Occult Node-Positive Clinical Stage IA Lung CancerTamar B Nobel, Kay See Tan, Prasad S Adusumilli, et al.
Annals of Surgery|January 25, 2020
Outcomes After Multidisciplinary Management of Primary Mediastinal Germ Cell TumorsRaul Caso, Gregory D Jones, Manjit S Bains, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancerHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
JTCVS Open|December 31, 2025
The role of diagnostic laparoscopy in staging distal esophageal adenocarcinomaStella T Tsui, Nanruoyi Zhou, Kay See Tan, et al.
Frontiers in Oncology|January 25, 2021
MYBL2-Driven Transcriptional Programs Link Replication Stress and Error-prone DNA Repair With Genomic Instability in Lung AdenocarcinomaBenjamin B Morris, Nolan A Wages, Patrick A Grant, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 19, 2021
Long-term assessment of efficacy with a novel Thoracic Survivorship Program for patients with lung cancerHari B Keshava, Kay See Tan, Joe Dycoco, et al.
Molecular Cancer Therapeutics|September 19, 2019
Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of <i>Nf1</i>-Deficient MiceCiersten A Burks, Steven D Rhodes, Waylan K Bessler, et al.
The Journal of Thoracic and Cardiovascular Surgery|November 13, 2018
Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysisWhitney S Brandt, Wanpu Yan, Jian Zhou, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 16, 2014
Analysis of longitudinal quality-of-life data in high-risk operable patients with lung cancer: results from the ACOSOG Z4032 (Alliance) multicenter randomized trialHiran C Fernando, Rodney J Landreneau, Sumithra J Mandrekar, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 28, 2022
Postinduction therapy pulmonary function retesting is necessary before surgical resection for non-small cell lung cancerJames G Connolly, Megan Fiasconaro, Kay See Tan, et al.
Pageof 66